133 related articles for article (PubMed ID: 9494556)
21. Kinetics of the inhibition of acetylcholinesterase from desert cobra (Walterinnesia aegyptia) venom by local anesthetics: procaine and tetracaine.
al-Jafari AA; Kamal MA; Duhaiman AS; Alhomida AS
J Enzyme Inhib; 1996 Oct; 11(2):123-34. PubMed ID: 9204401
[TBL] [Abstract][Full Text] [Related]
22. Indirect parasympathomimetic activity of metoclopramide: reversible inhibition of cholinesterases from human central nervous system and blood.
Chemnitius JM; Haselmeyer KH; Gonska BD; Kreuzer H; Zech R
Pharmacol Res; 1996; 34(1-2):65-72. PubMed ID: 8981558
[TBL] [Abstract][Full Text] [Related]
23. Kinetics of human acetylcholinesterase inhibition by the novel experimental Alzheimer therapeutic agent, tolserine.
Kamal MA; Greig NH; Alhomida AS; Al-Jafari AA
Biochem Pharmacol; 2000 Aug; 60(4):561-70. PubMed ID: 10874131
[TBL] [Abstract][Full Text] [Related]
24. Mercuric chloride effects on the kinetic parameters of human erythrocyte membrane bound acetylcholinesterase.
Aijafari AA
Biochem Mol Biol Int; 1995 Aug; 36(6):1243-53. PubMed ID: 8535296
[TBL] [Abstract][Full Text] [Related]
25. Human erythrocyte acetylcholinesterase inhibition by cis-diamminediaquaplatinum (II): a novel kinetic approach.
Kamal MA; Nasim FH; Al-Jafari AA
Cancer Lett; 1999 Apr; 138(1-2):115-9. PubMed ID: 10378782
[TBL] [Abstract][Full Text] [Related]
26. Thermodynamic investigation of camel retina acetylcholinesterase inhibition by cyclophosphamide.
al-Jafari AA; Kamal MA; Alhomida AS
J Enzyme Inhib; 1997 Feb; 11(4):275-83. PubMed ID: 9208370
[TBL] [Abstract][Full Text] [Related]
27. The toxicological effect of cyclophosphamide on acetylcholinesterase activity.
al-Jafari AA
Toxicol Lett; 1993 Feb; 66(2):125-31. PubMed ID: 8430432
[TBL] [Abstract][Full Text] [Related]
28. Investigation of the effect of anti-neoplastic drugs, cyclophosphamide, cisplatin and methotrexate on the turnover kinetics of human erythrocyte acetylcholinesterase.
Kamal MA; Nasim FH; al-Jafari AA
Biochem Mol Biol Int; 1996 May; 39(2):293-302. PubMed ID: 8799456
[TBL] [Abstract][Full Text] [Related]
29. Kinetics and structure-activity relationship studies on pregnane-type steroidal alkaloids that inhibit cholinesterases.
Khalid A; Zaheer-ul-Haq ; Anjum S; Khan MR; Atta-ur-Rahman ; Choudhary MI
Bioorg Med Chem; 2004 May; 12(9):1995-2003. PubMed ID: 15080903
[TBL] [Abstract][Full Text] [Related]
30. Kinetics for the inhibition of acetylcholinesterase from human erythrocyte by cisplatin.
Aljafari AA
Int J Biochem Cell Biol; 1995 Sep; 27(9):965-70. PubMed ID: 7584632
[TBL] [Abstract][Full Text] [Related]
31. Human platelet acetylcholinesterase inhibition by cyclophosphamide: a combined experimental and computational approach.
Al-Jafari AA; Shakil S; Reale M; Kamal MA
CNS Neurol Disord Drug Targets; 2011 Dec; 10(8):928-35. PubMed ID: 22229321
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of two different cholinesterases by tacrine.
Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
[TBL] [Abstract][Full Text] [Related]
33. The preparation and kinetic analysis of multiple forms of human erythrocyte acetylcholinesterase.
Kamal MA; al-Jafari AA
Prep Biochem Biotechnol; 1996 May; 26(2):105-19. PubMed ID: 8784921
[TBL] [Abstract][Full Text] [Related]
34. Indirect parasympathomimetic activity of the class III antiarrhythmic substance D/L-sotalol in vitro: reversible inhibition of cholinesterase isoenzymes from blood and the human central nervous system.
Chemnitius JM; Schahmirzadi F; Gonska BD; Kreuzer H; Zech R
Pharmacol Res; 1996; 34(5-6):193-200. PubMed ID: 9076843
[TBL] [Abstract][Full Text] [Related]
35. Thermodynamic analysis of human retinal acetylcholinesterase inhibition using an anti-Alzheimer's drug, tacrine, through the development of a dual substrate and temperature model.
Kamal MA; Alhomida AS; Al-Rajhi AA; Al-Jafari AA
Proc Natl Sci Counc Repub China B; 2000 Jul; 24(3):108-15. PubMed ID: 10943943
[TBL] [Abstract][Full Text] [Related]
36. Kinetic evidence for the allosteric substrate inhibition of human erythrocyte acetylcholinesterase.
Niday E; Wang CS; Alaupovic P
Biochim Biophys Acta; 1980 Mar; 612(1):67-72. PubMed ID: 7362833
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the oxime-induced reactivation of rhesus monkey, swine and guinea pig erythrocyte acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity.
Herkert NM; Lallement G; Clarençon D; Thiermann H; Worek F
Toxicology; 2009 Apr; 258(2-3):79-83. PubMed ID: 19428926
[TBL] [Abstract][Full Text] [Related]
38. Ambenonium is a rapidly reversible noncovalent inhibitor of acetylcholinesterase, with one of the highest known affinities.
Hodge AS; Humphrey DR; Rosenberry TL
Mol Pharmacol; 1992 May; 41(5):937-42. PubMed ID: 1588924
[TBL] [Abstract][Full Text] [Related]
39. Multiple approaches to analyse the data for rat brain acetylcholinesterase inhibition by cyclophosphamide.
Kamal MA; Reale M; Al-Jafari AA
Neurochem Res; 2010 Oct; 35(10):1501-9. PubMed ID: 20652634
[TBL] [Abstract][Full Text] [Related]
40. Optimization and kinetic studies of human erythrocyte membrane-bound acetylcholinesterase.
al-Jafari AA; Kamal MA
Biochem Mol Biol Int; 1996 Mar; 38(3):577-86. PubMed ID: 8829618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]